PTAB Roundup

CAFC: Substantial evidence supports nonobviousness finding, and no patent eligibility review on appeal of IPR. The Court affirmed the PTAB’s nonobviousness finding, holding that substantial evidence supported the Board’s underlying findings of fact despite some other evidence to the contrary. In particular, substantial evidence supporting the PTAB’s findings included skepticism expressed by the FDA during …

Read More